## **Core Concept**
The question tests the understanding of paraneoplastic syndromes associated with lung cancer, specifically squamous cell carcinoma, and its relationship with hypercalcemia. Squamous cell carcinoma of the lung is known to cause hypercalcemia through the production of **parathyroid hormone-related protein (PTHrP)**, leading to **humoral hypercalcemia of malignancy**.

## **Why the Correct Answer is Right**
The correct answer, **PTHrP (Parathyroid hormone-related protein)**, is the probable cause of very high serum calcium levels in a patient with squamous cell carcinoma of the lung. PTHrP mimics the action of parathyroid hormone (PTH) by binding to PTH receptors in bone and kidney, leading to increased bone resorption and decreased renal excretion of calcium. This results in hypercalcemia, which is a common paraneoplastic syndrome in patients with squamous cell carcinoma of the lung.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Ectopic ACTH production is associated with small cell lung carcinoma, not squamous cell carcinoma, and leads to Cushing's syndrome, not hypercalcemia.
- **Option B:** While **Vitamin D analogs** can contribute to hypercalcemia, they are not the most direct or common cause associated with squamous cell carcinoma of the lung.
- **Option C:** **Tumor production of prostaglandins** can contribute to hypercalcemia but is less specific and less commonly associated with squamous cell carcinoma compared to PTHrP.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **squamous cell carcinoma of the lung** is the most common type of lung cancer associated with **hypercalcemia** due to its production of **PTHrP**. Recognizing this association can aid in the diagnosis and management of hypercalcemia in cancer patients.

## **Correct Answer:** D. Parathyroid hormone-related protein (PTHrP).